Role of CD8 T cell-mediated Pathology in Globoid Cell Leukodystrophy
CD8 T 细胞介导的病理学在球状细胞脑白质营养不良中的作用
基本信息
- 批准号:10634808
- 负责人:
- 金额:$ 51.91万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-03-01 至 2028-02-29
- 项目状态:未结题
- 来源:
- 关键词:5 year oldAddressAffectAntibodiesAntigen-Presenting CellsAntigensAutomobile DrivingBehavioralBiochemicalBloodBody Weight decreasedBrainCD4 Positive T LymphocytesCD8-Positive T-LymphocytesCD8B1 geneCell TherapyCellsCellular ImmunityCentral Nervous SystemCentral Nervous System DiseasesCessation of lifeChildClinicalCognitive deficitsComplexCytometryCytotoxic T-LymphocytesDataDemyelinationsDevelopmentDiseaseEffectivenessFlow CytometryFutureGenesGeneticGenetic DiseasesGloboid cell leukodystrophyHistologicHumanImageImmuneImmunityInflammationInflammatoryInvestigational TherapiesKnockout MiceKnowledgeLesionLife ExpectancyLipidsLive BirthLocationLongevityMapsMediatingMeningealModelingMolecularMotorMusMutationNatureNerve DegenerationNerve TissueNonsense CodonOligodendrogliaOnset of illnessOutcomeOutcome MeasureOutcome StudyParalysedPathogenesisPathogenicityPathologicPathologyPhenotypePlayPopulationProcessPsychosineReporter GenesRoleT cell clonalityT-Cell DepletionT-LymphocyteTechnologyTestingTherapeuticTherapeutic InterventionTimeTissuesTransgenic AnimalsTransgenic Organismsadaptive immunitybrain tissuecell typecentral nervous system demyelinating disordercytokinecytotoxic CD8 T cellscytotoxicitydefined contributiondisabilitygalactosylceramidasegene therapygenetic approachgenetic profilingimprovedinsightloss of functionloss of function mutationmouse modelmultidisciplinaryneuroinflammationneuropathologynovelpharmacologicpostnatalpreservationpreventresponsesingle-cell RNA sequencingspatial relationshipsuccesstooltranscriptome sequencingtranscriptomicswhite matter
项目摘要
Abstract
Globoid cell leukodystrophy (GLD) or Krabbe's disease is a fatal genetic demyelinating disease of the central
nervous system affecting 1 in 100,000 live births with no cure or effective long-term treatment. GLD is caused
by loss-of-function mutations in the galactosylceramidase (galc) gene, where loss of GALC enzymatic function
results in toxic accumulation of its substrate, a lipid called galactosylsphingosine or `psychosine'. Psychosine
cytotoxicity is considered the basis of several key pathologies in GLD. Neuropathology in GLD is marked by
profound demyelination and inflammation. However, molecular details of these processes are limited, leaving
few therapeutic options. Early histological evidence for CD8+ T cells within demyelinated lesions in both the twi
mouse brain and human GLD brain had suggested a role for adaptive immunity in this disease. However, the
function of CD8+ T cells in GLD has not been previously determined. To address this gap in our knowledge, we
analyzed the timing of T cell population changes by flow cytometry in CNS tissues from the twitcher mouse
model of GLD and compared with wt littermates. We identified a rapid and protracted elevation of T cells in the
twi CNS that was coincident with the onset of clinical disease at postnatal day 21 (P21). These data were
confirmed using single-cell RNA sequencing on twi and wt littermate brain tissues from which identified a 9-fold
increase in CD8+ T cells in twi mouse brains at P21. Our transcriptomic data also defined the CD8+ population
as cytotoxic T lymphocytes (CTLs). To test the function of CD8+ CTLs in GLD-like disease in twi mice, we
depleted CD8+ T cells by administering anti-CD8 antibody to twi mice and found that this treatment effectively
prevented disease onset, preserved wellness and completely prevented CNS demyelination while also
attenuating pro-inflammatory cytokine levels in brain and blood. These novel and highly translational data
portend a pathogenic role for CD8+ T cells in GLD and underlie the basis for our overall hypothesis that CD8+
T cells are pathogenic in GLD and directly contribute to disease. Accordingly, Aim 1 will characterize the
spatial and temporal development of CD8+ T cells in twi mice and challenge the contribution of CD8+ T cells
using knockout mouse lines to then assess clinical, biochemical, and pathological outcomes. Aim 2 will define
the overall nature of adaptive immunity by evaluating contribution of CD4+ T cells to CD8+ T cell-mediated
immunity in twi mice using targeted depletion and genetic strategies. Aim 3 will identify and profile the timing,
and location T cells responding to authentic antigen, the clonality of the T cells using T cell β chain VDJ
phenotyping, and then identify the nature of the antigen presenting cell types using transgenic reporter mice.
These multi-disciplinary studies will interrogate a previously unrecognized CD8+ T cell neuroinflammatory
response in GLD. Outcomes of these studies are expected to fill an important gap in our understanding on the
fundamental cellular pathological mechanisms underlying the development CD8+ T cell mediated
neuropathology and disease in GLD.
抽象的
球状细胞脑白质营养不良(GLD)或克拉伯氏病是一种遗传性致命的中枢神经脱髓鞘疾病
神经系统疾病会影响十分之一的活产儿,且无法治愈或长期有效治疗。
通过半乳糖神经酰胺酶 (galc) 基因的功能丧失突变,其中 GALC 酶功能丧失
导致其底物(一种称为半乳糖基鞘氨醇或“精神毒碱”的脂质)的毒性积累。
细胞毒性被认为是 GLD 中几种关键病理学的基础。
然而,这些过程的分子细节有限,导致广泛的脱髓鞘和炎症。
两者脱髓鞘病变内 CD8+ T 细胞的早期组织学证据很少。
小鼠大脑和人类 GLD 大脑表明适应性免疫在这种疾病中发挥着作用。
CD8+ T 细胞在 GLD 中的功能先前尚未确定。
通过流式细胞术分析了 twitcher 小鼠中枢神经系统组织中 T 细胞群变化的时间
GLD 模型并与 wt 同窝小鼠相比,我们发现 T 细胞快速且持久的升高。
twi CNS 与出生后第 21 天(P21)临床疾病的发作一致。
使用单细胞 RNA 测序对 twi 和 wt 同窝小鼠脑组织进行证实,从中鉴定出 9 倍
P21 时双胞胎小鼠大脑中 CD8+ T 细胞的增加我们的转录组数据也定义了 CD8+ 群体。
作为细胞毒性 T 淋巴细胞 (CTL) 为了测试 CD8+ CTL 在 Twi 小鼠中的 GLD 样疾病中的功能。
通过给双胞胎小鼠施用抗 CD8 抗体来耗尽 CD8+ T 细胞,并发现这种治疗有效
预防疾病发作,保持健康并完全预防中枢神经系统脱髓鞘,同时还
这些新颖且高度转化的数据降低了大脑和血液中的促炎细胞因子水平。
预示着 CD8+ T 细胞在 GLD 中的致病作用,并构成了我们总体假设的基础:CD8+
T 细胞在 GLD 中具有致病性并直接导致疾病,因此,目标 1 将描述该疾病的特征。
双胞胎小鼠中 CD8+ T 细胞的空间和时间发育并挑战 CD8+ T 细胞的贡献
使用基因敲除小鼠系来评估临床、生化和病理结果将定义目标 2。
通过评估 CD4+ T 细胞对 CD8+ T 细胞介导的贡献来评估适应性免疫的总体性质
使用目标消除和遗传策略对 Twi 小鼠进行免疫,Aim 3 将识别并分析时间,
并定位对真实抗原有反应的 T 细胞,使用 T 细胞 β 链 VDJ 确定 T 细胞的克隆性
表型分析,然后使用转基因报告小鼠鉴定抗原呈递细胞类型的性质。
这些多学科研究将探究以前未被识别的 CD8+ T 细胞神经炎症
这些研究的结果预计将填补我们对 GLD 理解的一个重要空白。
CD8+ T 细胞介导的发育的基本细胞病理机制
GLD 中的神经病理学和疾病。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Stephen J Crocker其他文献
Stephen J Crocker的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Stephen J Crocker', 18)}}的其他基金
The Contribution of Central Nervous System Demyelination to Bladder Dysfuntion
中枢神经系统脱髓鞘对膀胱功能障碍的影响
- 批准号:
10352892 - 财政年份:2021
- 资助金额:
$ 51.91万 - 项目类别:
Proteomic and Functional Analyses of Astrocyte Exosomes
星形胶质细胞外泌体的蛋白质组学和功能分析
- 批准号:
8893411 - 财政年份:2015
- 资助金额:
$ 51.91万 - 项目类别:
Development of a conditional T1MP-1 knockout mouse
条件性T1MP-1基因敲除小鼠的研制
- 批准号:
8417649 - 财政年份:2012
- 资助金额:
$ 51.91万 - 项目类别:
Development of a conditional T1MP-1 knockout mouse
条件性T1MP-1基因敲除小鼠的研制
- 批准号:
8283645 - 财政年份:2012
- 资助金额:
$ 51.91万 - 项目类别:
相似国自然基金
时空序列驱动的神经形态视觉目标识别算法研究
- 批准号:61906126
- 批准年份:2019
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
本体驱动的地址数据空间语义建模与地址匹配方法
- 批准号:41901325
- 批准年份:2019
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
大容量固态硬盘地址映射表优化设计与访存优化研究
- 批准号:61802133
- 批准年份:2018
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
针对内存攻击对象的内存安全防御技术研究
- 批准号:61802432
- 批准年份:2018
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
IP地址驱动的多径路由及流量传输控制研究
- 批准号:61872252
- 批准年份:2018
- 资助金额:64.0 万元
- 项目类别:面上项目
相似海外基金
Mobile phone-based screening for anemia in young children in western Kenya
基于手机的肯尼亚西部幼儿贫血筛查
- 批准号:
10752968 - 财政年份:2023
- 资助金额:
$ 51.91万 - 项目类别:
mHealth OAE: Towards Universal Newborn Hearing Screening in Kenya (mTUNE)
mHealth OAE:迈向肯尼亚全民新生儿听力筛查 (mTUNE)
- 批准号:
10738905 - 财政年份:2023
- 资助金额:
$ 51.91万 - 项目类别:
A Sample-to-Answer Point-of-Care Diagnostic for Recently Transfused Sickle Cell Anemia Patients in Low Resource Settings
针对资源匮乏地区最近输血的镰状细胞性贫血患者的从样本到答案的护理点诊断
- 批准号:
10564553 - 财政年份:2023
- 资助金额:
$ 51.91万 - 项目类别:
Neurocognitive Mechanisms Linking Early Parent-Child Relationship Quality to Transdiagnostic Psychopathology at School Age
将早期亲子关系质量与学龄跨诊断精神病理学联系起来的神经认知机制
- 批准号:
10607038 - 财政年份:2023
- 资助金额:
$ 51.91万 - 项目类别:
Testing Technology-Based Implementation Strategies for a Family-Based Pediatric Health Behavior Intervention in Community-Based Primary Care: A Cluster Randomized Factorial Trial
测试基于技术的社区初级保健中基于家庭的儿科健康行为干预的实施策略:整群随机析因试验
- 批准号:
10738964 - 财政年份:2023
- 资助金额:
$ 51.91万 - 项目类别: